MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) Secures 9.3 MW Power and Land for Flagship Utah Data Center
BluSky AI (OTC: BSAI), a developer of modular AI data center infrastructure, announced the acquisition of its first operational site in Central, Utah, securing 9.3 MW of grid-connected power through an agreement with Digital Asset…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen…
-
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple…
-
BlueSky AI Inc. (BSAI) Expands Market Presence with Strategic Milestones in AI Infrastructure
BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable…
-
Nutriband Inc. (NASDAQ: NTRB) Added to Four Key Indexes, Rethinking Opioid Safety in a Time of Crisis
The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe pain, their high abuse potential has led to…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Continues to Target Data Center Boom with Renewable Energy Focus Amid Soaring AI Power Demands
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Expands Performance-Driven Portfolio with ‘Fast Motion’
Newton Golf Company (NASDAQ: NWTG) is positioned for opportunity as it brings innovation to golf players seeking performance gains. The company recently launched its latest product: the Fast Motion shaft family, aiming to redefine performance standards…
-
MissionIRNewsBreaks – FAVO Capital Inc. (FAVO) Poised in New Era for Tech-Enabled SMB Lending
As the private credit market continues to evolve, FAVO Capital (OTC: FAVO) is positioned to capitalize on emerging opportunities. “FAVO stands out as a leading private credit provider, specializing in delivering fast, efficient and personalized funding solutions…
-
MissionIRNewsBreaks – Why Solowin Holdings (NASDAQ: SWIN) Is ‘One to Watch’
Solowin Holdings (NASDAQ: SWIN) is focused on delivering comprehensive investment solutions from traditional finance as well as decentralized finance to high-net-worth and institutional clients. “Operating through its wholly owned subsidiary, Solomon JFZ (Asia) Holdings Limited, Solowin…
-
Soligenix Inc. (NASDAQ: SNGX) Highlights Encouraging Phase 3 Progress for HyBryte(TM) in Investment Webinar
In a recent webinar hosted by Allele Capital, Soligenix (NASDAQ: SNGX) executives Dr. Christopher Schaber and Dr. Christopher Pullion shared detailed updates on the company’s HyBryte(TM) (synthetic hypericin) clinical development (https://ibn.fm/dz7eO). The event offered an in-depth look…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution
Nutriband (NASDAQ: NTRB) has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution. CEO Gareth Sheridan called the inclusion a…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Amends Payment Schedule for Iska Iska Interest, Updates Adjacent Property Agreement
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) has reached a mutual agreement with Empresa Minera Villegas S.R.L. to amend the payment terms for acquiring 100% interest in the Iska Iska silver-tin polymetallic project in…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advancing Novel Immunotherapy to Combat Antibiotic Resistance
Soligenix (NASDAQ: SNGX) is at the forefront of the effort as the medical community urgently seeks alternative treatments for bacterial infections in the face of escalating antibiotic resistance. The company’s SGX943 therapy “is based on dusquetide,…
-
MissionIRNewsBreaks – Why Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company, is leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR(R) (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
Clene (NASDAQ: CLNN) announced key regulatory developments following a Type C meeting with the FDA, where it received feedback on its statistical analysis plan (SAP) for evaluating neurofilament light (NfL) biomarker data from its Expanded Access…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push toward regulatory approval of NRX-100, a preservative-free intravenous ketamine formulation. The company has filed an…
-
Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, recently reported an encouraging clinical outcome in its Phase 2 HARMONIC(TM) trial, where a patient with…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough After Scientist Wins Top Italian Dermatology Award
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Srl has won the “Oscar of Italian Dermatology” from SIDeMaST for her research on PC111, a…
-
MissionIRNewsBreaks – FAVO Capital Inc. (FAVO) Eyes Opportunity at Crossroads of Fintech Innovation, Lending Demand
As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market. With policymakers calling for renewed focus on small business financing and…
-
MissionIRNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening…
-
D-Wave Quantum Inc. (NYSE: QBTS) Partners with Yonsei University and Incheon City to Advance Quantum Adoption in South Korea
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has entered into a strategic partnership with Yonsei University and Incheon Metropolitan City designed to accelerate quantum computing adoption and…
-
MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch
NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, has engaged IBN to manage its corporate communications strategy. NRx is advancing two FDA-designated therapies—NRX-100 and NRX-101—with an NDA…
-
MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Acquires Nautical Ventures to Launch First Integrated Electric Boat Dealership in North America
Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion, has acquired Nautical Ventures Group, a top U.S. boat dealership and 2024 Boating Industry “Dealer of the Year.” The move establishes North America’s…
-
Vivakor Inc. (NASDAQ: VIVK): A Modern Answer to Oil’s Dirty Problem
Despite growing investment in renewable energy, the world continues to run on oil and will for decades to come. From manufacturing solar panels to powering global transport, fossil fuels remain deeply embedded in every corner…
-
MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation
NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner’s National Priority Voucher (CNPV) program, seeking accelerated review for NRX-100, its preservative-free intravenous ketamine formulation. The company believes NRX-100 meets all criteria outlined…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone
Nutriband (NASDAQ: NTRB) has received a new $15 price target in an updated report from Robert LeBoyer, Senior Vice President and Equity Research Analyst, Biotechnology, at Noble Capital Markets, following the successful completion of commercial…
-
Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation
The opioid crisis remains one of the most persistent public health emergencies in the U.S. While state and federal initiatives have helped curb some of the worst-case trajectories, more than 100,000 Americans still die each year from drug overdoses,…
-
Vivakor Inc. (NASDAQ: VIVK) Pioneers Sustainable Oilfield Waste Management
In an era where environmental responsibility intersects with energy production, Vivakor (NASDAQ: VIVK) stands out as a vertically integrated energy infrastructure and environmental services company focused on the transportation, storage, reuse and remediation of oilfield fluids and…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that it has signed a memorandum of understanding (MOU) with Yonsei University and Incheon Metropolitan City aimed at accelerating quantum…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Among Early Adopters of Bitcoin Treasury Strategies Amid Growing Trend
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
MissionIRNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS’ Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote…
Search Articles
Latest Articles
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial
- MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Receives Court Approval for Shareholder Claim Settlement